Exhibit
10.1
INVESTMENT
AGREEMENT
INVESTMENT
AGREEMENT (this "AGREEMENT"), dated as of February 25, 2005 by and
between HouseRaising, Inc., a North Carolina corporation (the
"Company"), and Dutchess Private Equities Fund, II, LP, a Delaware
limited partnership (the "Investor").
Whereas, the
parties desire that, upon the terms and subject to the conditions
contained herein, the Investor shall invest up to Twelve Million
dollars ($12,000,000) to purchase the Company's Common Stock, $.001
par value per share (the "Common Stock");
Whereas, such
investments will be made in reliance upon the provisions of Section
4(2) under the Securities Act of 1933, as amended (the "1933 Act"),
Rule 506 of Regulation D, and the rules and regulations promulgated
thereunder, and/or upon such other exemption from the registration
requirements of the 1933 Act as may be available with respect to
any or all of the investments in Common Stock to be made hereunder;
and
Whereas,
contemporaneously with the execution and delivery of this
Agreement, the parties hereto are executing and delivering a
Registration Rights Agreement substantially in the form attached
hereto (as amended from time to time, the "Registration Rights
Agreement") pursuant to which the Company has agreed to provide
certain registration rights under the 1933 Act, and the rules and
regulations promulgated thereunder, and applicable state securities
laws.
NOW THEREFORE,
in consideration of the foregoing recitals, which shall be
considered an integral part of this Agreement, the covenants and
agreements set forth hereafter, and other good and valuable
consideration, the receipt and sufficiency of which is hereby
acknowledged, the Company and the Investor hereby agree as
follows:
As used in this Agreement, the following terms
shall have the following meanings specified or indicated below, and
such meanings shall be equally applicable to the singular and
plural forms of such defined terms.
“ 1933 Act ” shall have the
meaning set forth in the preamble of this agreement.
“ 1934 Act ” shall mean the
Securities Exchange Act of 1934, as it may be amended.
“ Affiliate ” shall have the
meaning specified in Section 5(h), below.
“ Agreement ” shall mean this
Investment Agreement.
“ Best Bid” shall mean the
highest posted bid price of the Common Stock.
“ Buy In ” shall have the
meaning specified in Section 6, below.
“ Buy In Adjustment Amount ”
shall have the meaning specified in Section 6.
“ Closing ” shall have the
meaning specified in Section 2(h).
“ Closing Date ” shall mean
no more than seven (7) Trading Days following the Put Notice
Date.
“ Common Stock ” shall have
the meaning set forth in the preamble of this Agreement.
“ Control ” or “
Controls ” shall have the meaning specified in Section
5(h).
“ Covering Shares ” shall
have the meaning specified in Section 6.
“ Effective Date ” shall mean
the date the SEC declares effective under the 1933 Act the
Registration Statement covering the Securities.
“ Environmental Laws ” shall
have the meaning specified in Section 4(m).
“ Execution Date ” shall mean
the date indicated in the preamble to this Agreement.
“ Indemnities ” shall have
the meaning specified in Section 11.
“ Indemnified Liabilities ”
shall have the meaning specified in Section 11.
“ Ineffective Period ” shall
mean any period of time that the Registration Statement or any
Supplemental Registration Statement (as defined in the Registration
Rights Agreement) becomes ineffective or unavailable for use for
the sale or resale, as applicable, of any or all of the Registrable
Securities (as defined in the Registration Rights Agreement) for
any reason (or in the event the prospectus under either of the
above is not current and deliverable) during any time period
required under the Registration Rights Agreement.
“ Investor ” shall have the
meaning indicated in the preamble of this Agreement.
“ Material Adverse Effect ”
shall have the meaning specified in Section 4(a).
“ Maximum Common Stock Issuance
” shall have the meaning specified in Section
2(I).
“ Minimum Acceptable Price ”
with respect to any Put Notice Date shall mean seventy-five percent
(75%) of the lowest closing bid prices for the ten (10) Trading Day
period immediately preceding such Put Notice Date.
“ Open
Period ” shall mean the period beginning on and including
the Trading Day immediately following the Effective Date and ending
on the earlier to occur of (i) the date which is
thirty-six (36) months from the Effective Date; or
(ii) termination of the Agreement in accordance
with Section 9, below.
“ Pricing Period ” shall mean
the period beginning on the Put Notice Date and ending on and
including the date that is five (5) Trading Days after such Put
Notice Date.
“ Principal Market ” shall
mean the American Stock Exchange, Inc., the National Association of
Securities Dealers, Inc. Over-the-Counter Bulletin Board, the
NASDAQ National Market System or the NASDAQ SmallCap Market,
whichever is the principal market on which the Common Stock is
listed.
“ Prospectus ” shall mean the
prospectus, preliminary prospectus and supplemental prospectus used
in connection with the Registration Statement.
“ Purchase Amount ” shall
mean the total amount being paid by the Investor on a particular
Closing Date to purchase the Securities.
“ Purchase Price ” shall mean
ninety-five percent (95%) of the lowest closing Best Bid price of
the Common Stock during the Pricing Period.
“ Put Amount ” shall have the
meaning set forth in Section 2(b) hereof.
“ Put Notice ” shall mean a
written notice sent to the Investor by the Company stating the Put
Amount in U.S. dollars, the Company intends to sell to the Investor
pursuant to the terms of the Agreement and stating the current
number of Shares issued and outstanding on such date.
“ Put Notice Date ” shall
mean the Trading Day immediately following the day on which the
Investor receives a Put Notice, however a Put Notice shall be
deemed delivered on (a) the Trading Day it is
received by facsimile or otherwise by the Investor if such notice
is received prior to 9:00 am Eastern Time, or (b)
the immediately succeeding Trading Day if it is received by
facsimile or otherwise after 9:00 am Eastern Time on a Trading Day.
No Put Notice may be deemed delivered on a day that is not a
Trading Day.
“ Put Restriction ” shall
mean the days between the beginning of the Pricing Period and
Closing Date. During this time, the Company shall not be entitled
to deliver another Put Notice.
“ Registration Period ” shall
have the meaning specified in Section 5(c), below.
“ Registration Rights Agreement
” shall have the meaning set forth in the recitals,
above.
“ Registration Statement ”
means the registration statement of the Company filed under the
1933 Act covering the Common Stock issuable hereunder.
“ Related Party ” shall have
the meaning specified in Section 5(h).
“ Resolution ” shall have the
meaning specified in Section 8(e).
“ SEC ” shall mean the U.S.
Securities & Exchange Commission.
“ SEC Documents ” shall have
the meaning specified in Section 4(f).
“ Securities ” shall mean the
shares of Common Stock issued pursuant to the terms of the
Agreement.
“ Shares ” shall mean the
shares of the Company’s Common Stock.
“ Sold Shares ” shall have
the meaning specified in Section 6.
“ Subsidiaries ” shall have
the meaning specified in Section 4(a).
“ Trading Day ” shall mean
any day on which the Principal Market for the Common Stock is open
for trading, from the hours of 9:30 am until 4:00 pm.
“ Transaction Documents ”
shall mean this Agreement, the Registration Rights Agreement, and
each of the other agreements entered into by the parties hereto in
connection with this Agreement.
SECTION 2.
PURCHASE AND SALE OF COMMON STOCK.
(A) PURCHASE
AND SALE OF COMMON STOCK. Subject to the terms and conditions set
forth herein, the Company shall issue and sell to the Investor, and
the Investor shall purchase from the Company, up to that number of
Shares having an aggregate Purchase Price of Twelve Million dollars
($12,000,000).
(B) DELIVERY OF
PUT NOTICES.
(I) Subject to
the terms and conditions of the Transaction Documents, and from
time to time during the Open Period, the Company may, in its sole
discretion, deliver a Put Notice to the Investor which states the
Put Amount (designated in U.S. Dollars) which the Company intends
to sell to the Investor on a Closing Date. The Put Notice shall be
in the form attached hereto as Exhibit F and incorporated herein by
reference. The amount that the Company shall be entitled to Put to
the Investor (the "Put Amount") shall be equal to, at the Company's
election, either: (A) Two Hundred percent (200%) of the average
daily volume (U.S. market only) of the Common Stock for the ten
(10) Trading Days prior to the applicable Put Notice Date,
multiplied by the average of the three (3) daily closing bid prices
immediately preceding the Put Date, or (B) One Hundred Thousand
dollars ($100,000); provided that in no event will the Put Amount
be more than One Million Dollars ($1,000,000) with respect to any
single Put. During the Open Period, the Company shall not be
entitled to submit a Put Notice until after the previous Closing
has been completed. The Purchase Price for the Common Stock
identified in the Put Notice shall be equal to ninety-five percent
(95%) of the lowest closing Best Bid price of the Common Stock
during the Pricing Period.
(II) If any
closing bid price during the applicable Pricing Period with respect
to that Put Notice is less than Seventy-Five percent (75%) of the
closing bid prices of the Common Stock for the ten (10) Trading
Days prior to the Put Notice Date (the "Minimum Acceptable Price"),
the Put Notice will terminate at the Company's request. In the
event that the closing bid price for the applicable Pricing Period
is less than the Minimum Acceptable Price, the Company may elect,
by sending written notice to the Investor to cancel the Put
Notice.
(D) INVESTOR'S
OBLIGATION TO PURCHASE SHARES. Subject to the conditions set forth
in this Agreement, following the Investor's receipt of a validly
delivered Put Notice, the Investor shall be required to purchase
from the Company during the related Pricing Period that number of
Shares having an aggregate Purchase Price equal to the lesser of
(i) the Put Amount set forth in the Put Notice, and (ii) twenty
percent (20%) of the aggregate trading volume of the Common Stock
during the applicable Pricing Period times (x) the average of the
lowest closing Best Bid prices of the Company's Common Stock during
the specified Pricing Period, but only if said Shares bear no
restrictive legend, are not subject to stop transfer instructions,
pursuant to Section 2(h), prior to the applicable Closing
Date.
(F) CONDITIONS
TO INVESTOR'S OBLIGATION TO PURCHASE SHARES. Notwithstanding
anything to the contrary in this Agreement, the Company shall not
be entitled to deliver a Put Notice and the Investor shall not be
obligated to purchase any Shares at a Closing (as defined in
Section 2(h)) unless each of the following conditions are
satisfied:
(I) a
Registration Statement shall have been declared effective and shall
remain effective and available for the resale of all the
Registrable Securities (as defined in the Registration Rights
Agreement) at all times until the Closing with respect to the
subject Put Notice;
(II) at all
times during the period beginning on the related Put Notice Date
and ending on and including the related Closing Date, the Common
Stock shall have been listed on the Principal Market and shall not
have been suspended from trading thereon for a period of two (2)
consecutive Trading Days during the Open Period and the Company
shall not have been notified of any pending or threatened
proceeding or other action to suspend the trading of the Common
Stock;
(III) the
Company has complied with its obligations and is otherwise not in
breach of a material provision of, or in default under, this
Agreement, the Registration Rights Agreement or any other agreement
executed in connection herewith which has not been corrected prior
to delivery of the Put Notice Date;
(IV) no
injunction shall have been issued and remain in force, or action
commenced by a governmental authority which has not been stayed or
abandoned, prohibiting the purchase or the issuance of the
Securities; and
(V) the
issuance of the Securities will not violate any shareholder
approval requirements of the Principal Market.
If any of the
events described in clauses (i) through (v) above occurs during a
Pricing Period, then the Investor shall have no obligation to
purchase the Put Amount of Common Stock set forth in the applicable
Put Notice.
(H) MECHANICS
OF PURCHASE OF SHARES BY INVESTOR. Subject to the satisfaction of
the conditions set forth in Sections 2(f), 7 and 8, the closing of
the purchase by the Investor of Shares (a "Closing") shall occur on
the date which is no later than seven (7) Trading Days following
the applicable Put Notice Date (each a "Closing Date"). Prior to
each Closing Date, (I) the Company shall deliver to the Investor
pursuant to this Agreement, certificates representing the Shares to
be issued to the Investor on such date and registered in the name
of the Investor; and (II) the Investor shall deliver to the Company
the Purchase Price to be paid for such Shares, determined as set
forth in Sections 2(b) and 2(d). In lieu of delivering physical
certificates representing the Securities and provided that the
Company's transfer agent then is participating in The Depository
Trust Company ("DTC") Fast Automated Securities Transfer ("FAST")
program, upon request of the Investor, the Company shall use its
commercially reasonable efforts to cause its transfer agent to
electronically transmit the Securities by crediting the account of
the Investor's prime broker (which shall be specified by the
Investor a reasonably sufficient time in advance) with DTC through
its Deposit Withdrawal Agent Commission ("DWAC") system.
The Company
understands that a delay in the issuance of Securities beyond the
Closing Date could result in economic loss to the Investor. After
the Effective Date, as compensation to the Investor for such loss,
the Company agrees to pay late payments to the Investor for late
issuance of Securities (delivery of Securities after the applicable
Closing Date) in accordance with the following schedule (where "No.
of Days Late" is defined as the number of trading days beyond the
Closing Date. The Amounts are cumulative.):
LATE PAYMENT
FOR EACH NO. OF DAYS LATE
|
$10,000 OF
COMMON STOCK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$1,000 + $200
for each Business Day late beyond 10 days
|
The Company
shall pay any payments incurred under this Section in immediately
available funds upon demand by the Investor. Nothing herein shall
limit the Investor's right to pursue actual damages for the
Company's failure to issue and deliver the Securities to the
Investor, except to the extent that such late payments shall
constitute payment for and offset any such actual damages alleged
by the Investor, and any Buy In Adjustment Amount.
(I) OVERALL
LIMIT ON COMMON STOCK ISSUABLE. Notwithstanding anything contained
herein to the contrary, if during the Open Period the Company
becomes listed on an exchange that limits the number of shares of
Common Stock that may be issued without shareholder approval, then
the number of Shares issuable by the Company and purchasable by the
Investor, including the shares of Common Stock issuable to the
Investors, shall not exceed that number of the shares of Common
Stock that may be issuable without shareholder approval, subject to
appropriate adjustment for stock splits, stock dividends,
combinations or other similar recapitalization affecting the Common
Stock (the "Maximum Common Stock Issuance"), unless the issuance of
Shares, including any Common Stock to be issued to the Investor
pursuant to Section 11(b), in excess of the Maximum Common Stock
Issuance shall first be approved by the Company's shareholders in
accordance with applicable law and the By-laws and Amended and
Restated Certificate of Incorporation of the Company, if such
issuance of shares of Common Stock could cause a delisting on the
Principal Market. The parties understand and agree that the
Company's failure to seek or obtain such shareholder approval shall
in no way adversely affect the validity and due authorization of
the issuance and sale of Securities or the Investor's obligation in
accordance with the terms and conditions hereof to purchase a
number of Shares in the aggregate up to the Maximum Common Stock
Issuance limitation, and that such approval pertains only to the
applicability of the Maximum Common Stock Issuance limitation
provided in this Section 2(j).
SECTION 3.
INVESTOR'S REPRESENTATIONS, WARRANTIES AND COVENANTS.
The Investor
represents and warrants to the Company, and covenants,
that:
(A)
SOPHISTICATED INVESTOR. The Investor has, by reason of its business
and financial experience, such knowledge, sophistication and
experience in financial and business matters and in making
investment decisions of this type that it is capable of (I)
evaluating the merits and risks of an investment in the Securities
and making an informed investment decision; (II) protecting its own
interest; and (III) bearing the economic risk of such investment
for an indefinite period of time.
(B)
AUTHORIZATION; ENFORCEMENT. This Agreement has been duly and
validly authorized, executed and delivered on behalf of the
Investor and is a valid and binding agreement of the Investor
enforceable against the Investor in accordance with its terms,
subject as to enforceability to general principles of equity and to
applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting
generally, the enforcement of applicable creditors' rights and
remedies.
(C) SECTION 9
OF THE 1934 ACT. During the term of this Agreement, the Investor
will comply with the provisions of Section 9 of the 1934 Act, and
the rules promulgated thereunder, with respect to transactions
involving the Common Stock. The Investor agrees not to short,
either directly or indirectly through its affiliates, principals or
advisors, the Company's common stock during the term of this
Agreement.
(D) ACCREDITED
INVESTOR. Investor is an "Accredited Investor" as that term is
defined in Rule 501(a)(3) of Regulation D of the 1933
Act.
(E) NO
CONFLICTS. The execution, delivery and performance of the
Transaction Documents by the Investor and the consummation by the
Investor of the transactions contemplated hereby and thereby will
not result in a violation of Partnership Agreement or other
organizational documents of the Investor.
(F) OPPORTUNITY
TO DISCUSS. The Investor has received all materials relating to the
Company's business, finance and operations which it has requested.
The Investor has had an opportunity to discuss the business,
management and financial affairs of the Company with the Company's
management.
(G) INVESTMENT
PURPOSES. The Investor is purchasing the Securities for its own
account for investment purposes and not with a view towards
distribution and agrees to resell or otherwise dispose of the
Securities solely in accordance with the registration provisions of
the 1933 Act (or pursuant to an exemption from such registration
provisions).
(H) NO
REGISTRATION AS A DEALER. The Investor is not and will not be
required to be registered as a "dealer" under the 1934 Act, either
as a result of its execution and performance of its obligations
under this Agreement or otherwise.
(I) GOOD
STANDING The Investor is a Limited Partnership, duly organized,
validly existing and in good standing in the State of
Delaware.
(J) TAX
LIABILITIES. The Investor understands that it is liable for its own
tax liabilities.
(K) REGULATION
M. The Investor will comply with Regulation M under the 1934 Act,
if applicable.
SECTION 4.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY.
Except as set
forth in the Schedules attached hereto, or as disclosed on the
Company's SEC Documents, the Company represents and warrants to the
Investor that:
(A)
ORGANIZATION AND QUALIFICATION. The Company is a corporation duly
organized and validly existing in good standing under the laws of
the State of North Carolina, and has the requisite corporate power
and authorization to own its properties and to carry on its
business as now being conducted. Both the Company and the companies
it owns or controls, its “Subsidiaries,” are duly
qualified to do business and are in good standing in every
jurisdiction in which its ownership of property or the nature of
the business conducted by it makes such qualification necessary,
except to the extent that the failure to be so qualified or be in
good standing would not have a Material Adverse Effect. As used in
this Agreement, "Material Adverse Effect" means any material
adverse effect on the business, properties, assets, operations,
results of operations, financial condition or prospects of the
Company and its Subsidiaries, if any, taken as a whole, or on the
transactions contemplated hereby or by the agreements and
instruments to be entered into in connection herewith, or on the
authority or ability of the Company to perform its obligations
under the Transaction Documents (as defined in Section 1 and 4(b),
below).
(B)
AUTHORIZATION; ENFORCEMENT; COMPLIANCE WITH OTHER
INSTRUMENTS.
(I) The Company
has the requisite corporate power and authority to enter into and
perform this Agreement, the Registration Rights Agreement, and each
of the other agreements entered into by the parties hereto in
connection with the transactions contemplated by this Agreement
(collectively, the "Transaction Documents"), and to issue the
Securities in accordance with the terms hereof and
thereof.
(II) The
execution and delivery of the Transaction Documents by the Company
and the consummation by it, of the transactions contemplated hereby
and thereby, including without limitation the reservation for
issuance and the issuance of the Securities pursuant to this
Agreement, have been duly and validly authorized by the Company's
Board of Directors and no further consent or authorization is
required by the Company, its Board of Directors, or its
shareholders.
(III) The
Transaction Documents have been duly and validly executed and
delivered by the Company.
(IV) The
Transaction Documents constitute the valid and binding obligations
of the Company enforceable against the Company in accordance with
their terms, except as such enforceability may be limited by
general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating
to, or affecting generally, the enforcement of creditors' rights
and remedies.
(C)
CAPITALIZATION. As of the date hereof, the authorized capital stock
of the Company consists of (i) 100,000,000 shares of Common Stock,
$0.001 par value per share, of which as of the date hereof,
36,869,936 shares are issued and outstanding; 5,000,000 shares of
Preferred Stock authorized, $0.001 par value per share, of which as
of the date hereof, 1,000,000 shares of Class A Convertible
Preferred Stock are issued and outstanding; as of December 31,
2004, 9,384,696 shares were reserved for issuance pursuant to
options, warrants and other convertible securities. All of such
outstanding shares have been, or upon issuance will be, validly
issued and are fully paid and nonassessable. Except as disclosed in
the Company's publicly available filings with Periodic
Filings,
(I) no shares
of the Company's capital stock are subject to preemptive rights or
any other similar rights or any liens or encumbrances suffered or
permitted by the Company; (II) there are no outstanding debt
securities; (III) there are no outstanding shares of capital stock,
options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities
or rights convertible into, any shares of capital stock of the
Company or any of its Subsidiaries, or contracts, commitments,
understandings or arrangements by which the Company or any of its
Subsidiaries is or may become bound to issue additional shares of
capital stock of the Company or any of its Subsidiaries or options,
warrants, scrip, rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any
of its Subsidiaries; (IV) there are no agreements or arrangements
under which the Company or any of its Subsidiaries is obligated to
register the sale of any of their securities under the 1933 Act
(except the Registration Rights Agreement), (V) there are no
outstanding securities of the Company or any of its Subsidiaries
which contain any redemption or similar provisions, and there are
no contracts, commitments, understandings or arrangements by which
the Company or any of its Subsidiaries is or may become bound to
redeem a security of the Company or any of its Subsidiaries; (VI)
there are no securities or instruments containing anti-dilution or
similar provisions that will be triggered by the issuance of the
Securities as described in this Agreement; (VII) the Company does
not have any stock appreciation rights or "phantom stock" plans or
agreements or any similar plan or agreement; and (VIII) there is no
dispute as to the classification of any shares of the Company's
capital stock. The Company has furnished to the Investor, or the
Investor has had access through EDGAR to, true and correct copies
of the Company's Amended and Restated Certificate of Incorporation,
as in effect on the date hereof (the "Certificate of
Incorporation"), and the Company's By-laws, as in effect on the
date hereof (the "By-laws"), and the terms of all securities
convertible into or exercisable for Common Stock and the material
rights of the holders thereof in respect thereto.
(D) ISSUANCE OF
SHARES. The Company has reserved 6,000,000 Shares for issuance
pursuant to this Agreement has been duly authorized and reserved
for issuance (subject to adjustment pursuant to the Company's
covenant set forth in Section 5(f) below) pursuant to this
Agreement. Upon issuance in accordance with this Agreement, the
Securities will be validly issued, fully paid and non-assessable
and free from all taxes, liens and charges with respect to the
issue thereof. In the event the Company cannot register a
sufficient number of Shares for issuance pursuant to this
Agreement, the Company will use its best efforts to authorize and
reserve for issuance the number of Shares required for the Company
to perform its obligations hereunder as soon as reasonably
practicable.
(E) NO
CONFLICTS. The execution, delivery and performance of the
Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby will
not (I) result in a violation of the Certificate of Incorporation,
any Certificate of Designations, Preferences and Rights of any
outstanding series of preferred stock of the Company or the
By-laws; or (II) conflict with, or constitute a material default
(or an event which with notice or lapse of time or both would
become a material default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any
material agreement, contract, indenture mortgage, indebtedness or
instrument to which the Company or any of its Subsidiaries is a
party, or to the Company's knowledge result in a violation of any
law, rule, regulation, order, judgment or decree (including United
States federal and state securities laws and regulations and the
rules and regulations of the Principal Market or principal
securities exchange or trading market on which the Common Stock is
traded or listed) applicable to the Company or any of its
Subsidiaries or by which any property or asset of the Company or
any of its Subsidiaries is bound or affected. Except as disclosed
in Schedule 4(e), neither the Company nor its Subsidiaries is in
violation of any term of, or in default under, the Certificate of
Incorporation, any Certificate of Designations, Preferences and
Rights of any outstanding series of preferred stock of the Company
or the By-laws or their organizational charter or by-laws,
respectively, or any contract, agreement, mortgage, indebtedness,
indenture, instrument, judgment, decree or order or any statute,
rule or regulation applicable to the Company or its Subsidiaries,
except for possible conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations that would not
individually or in the aggregate have a Material Adverse Effect.
The business of the Company and its Subsidiaries is not being
conducted, and shall not be conducted, in violation of any law,
statute, ordinance, rule, order or regulation of any governmental
authority or agency, regulatory or self-regulatory agency, or
court, except for possible violations the sanctions for which
either individually or in the aggregate would not have a Material
Adverse Effect. Except as specifically contemplated by this
Agreement and as required under the 1933 Act to the Company's
knowledge, the Company is not required to obtain any consent,
authorization, permit or order of, or make any filing or
registration (except the filing of a registration statement) with,
any court, governmental authority or agency, regulatory or
self-regulatory agency or other third party in order for it to
execute, deliver or perform any of its obligations under, or
contemplated by, the Transaction Documents in accordance with the
terms hereof or thereof. All consents, authorizations, permits,
orders, filings and registrations which the Company is required to
obtain pursuant to the preceding sentence have been obtained or
effected on or prior to the date hereof and are in full force and
effect as of the date hereof. Except as disclosed in Schedule 4(e),
the Company and its Subsidiaries are unaware of any facts or
circumstances which might give rise to any of the foregoing. The
Company is not, and will not be, in violation of the listing
requirements of the Principal Market as in effect on the date
hereof and on each of the Closing Dates and is not aware of any
facts which would reasonably lead to delisting of the Common Stock
by the Principal Market in the foreseeable future.
(F) SEC
DOCUMENTS; FINANCIAL STATEMENTS. As of September 30, 2004, the
Company has filed all reports, schedules, forms, statements and
other documents required to be filed by it with the SEC pursuant to
the reporting requirements of the 1934 Act (all of the foregoing
filed prior to the date hereof and all exhibits included therein
and financial statements and schedules thereto and documents
incorporated by reference therein being hereinafter referred to as
the "SEC Documents"). The Company has delivered to the Investor or
its representatives, or they have had access through EDGAR to, true
and complete copies of the SEC Documents. As of their respective
dates, the SEC Documents complied in all material respects with the
requirements of the 1934 Act and the rules and regulations of the
SEC promulgated thereunder applicable to the SEC Documents, and
none of the SEC Documents, at the time they were filed with the
SEC, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under
which they were made, not misleading. As of their respective dates,
the financial statements of the Company included in the SEC
Documents complied as to form in all material respects with
applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto. Such financial
statements have been prepared in accordance with generally accepted
accounting principles, by a firm that is a member of the Public
Companies Accounting Oversight Board ("PCAOB") consistently
applied, during the periods involved (except (I) as may be
otherwise indicated in such financial statements or the notes
thereto, or (II) in the case of unaudited interim statements, to
the extent they may exclude footnotes or may be condensed or
summary statements) and fairly present in all material respects the
financial position of the Company as of the dates thereof and the
results of its operations and cash flows for the periods then ended
(subject, in the case of unaudited statements, to normal year-end
audit adjustments). No other written information provided by or on
behalf of the Company to the Investor which is not included in the
SEC Documents, including, without limitation, information referred
to in Section 4(d) of this Agreement, contains any untrue statement
of a material fact or omits to state any material fact necessary to
make the statements therein, in the light of the circumstance under
which they are or were made, not misleading. Neither the Company
nor any of its Subsidiaries or any of their officers, directors,
employees or agents have provided the Investor with any material,
nonpublic information which was not publicly disclosed prior to the
date hereof and any material, nonpublic information provided to the
Investor by the Company or its Subsidiaries or any of their
officers, directors, employees or agents prior to any Closing Date
shall be publicly disclosed by the Company prior to such Closing
Date.
(G) ABSENCE OF
CERTAIN CHANGES. Except as set forth in the SEC Documents, the
Company does not intend to change the business operations of the
Company in any material way. The Company has not taken any steps,
and does not currently expect to take any steps, to seek protection
pursuant to any bankruptcy law nor does the Company or its
Subsidiaries have any knowledge or reason to believe that its
creditors intend to initiate involuntary bankruptcy
proceedings.
(H) ABSENCE OF
LITIGATION. Except as set forth in the SEC Documents, there is no
action, suit, proceeding, inquiry or investigation before or by any
court, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the executive
officers of Company or any of its Subsidiaries, threatened against
or affecting the Company, the Common Stock or any of the Company's
Subsidiaries or any of the Company's or the Company's Subsidiaries'
officers or directors in their capacities as such, in which an
adverse decision could have a Material Adverse Effect.
(I)
ACKNOWLEDGMENT REGARDING INVESTOR'S PURCHASE OF SHARES. The Company
acknowledges and agrees that the Investor is acting solely in the
capacity of arm'